Biomedicines (Jun 2023)

Intraamygdaloid Oxytocin Increases Time Spent on Social Interaction in Valproate-Induced Autism Animal Model

  • Dávid Vörös,
  • Orsolya Kiss,
  • Tamás Ollmann,
  • Kitti Mintál,
  • László Péczely,
  • Olga Zagoracz,
  • Erika Kertes,
  • Veronika Kállai,
  • Bettina Réka László,
  • Beáta Berta,
  • Attila Toth,
  • László Lénárd,
  • Kristóf László

DOI
https://doi.org/10.3390/biomedicines11071802
Journal volume & issue
Vol. 11, no. 7
p. 1802

Abstract

Read online

Autism spectrum disorder (ASD) is a pervasive neurodevelopmental disorder that affects about 1.5% of children worldwide. One of the core symptoms is impaired social interaction. Since proper treatment has not been found yet, an investigation of the exact pathophysiology of autism is essential. The valproate (VPA)-induced rat model can be an appropriate way to study autism. Oxytocin (OT) may amend some symptoms of ASD since it plays a key role in developing social relationships. In the present study, we investigated the effect of the intraamygdaloid OT on sham and intrauterine VPA-treated rats’ social interaction using Crawley’s social interaction test. Bilateral guide cannulae were implanted above the central nucleus of the amygdala (CeA), and intraamygdaloid microinjections were carried out before the test. Our results show that male Wistar rats prenatally exposed to VPA spent significantly less time on social interaction. Bilateral OT microinjection increased the time spent in the social zone; it also reached the level of sham-control animals. OT receptor antagonist blocked this effect of the OT but in itself did not significantly influence the behavior of the rats. Based on our results, we can establish that intraamygdaloid OT has significantly increased time spent on social interaction in the VPA-induced autism model, and its effect is receptor-specific.

Keywords